A Framework to Evaluate the Cost-Effectiveness of the NADiA ProsVue Slope to Guide Adjuvant Radiotherapy Among Men With High-Risk Characteristics Following Prostatectomy for Prostate Cancer

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.04.010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

NADiA ProsVue Prostate-Specific Antigen Slope Is an Independent Prognostic Marker for Identifying Men at Reduced Risk of Clinical Recurrence of Prostate Cancer After Radical Prostatectomy

Urology
Urology
2012English

Comparative Effectiveness of Radical Prostatectomy With Adjuvant Radiotherapy Versus Radiotherapy Plus Androgen Deprivation Therapy for Men With Advanced Prostate Cancer

Cancer
Cancer ResearchOncology
2018English

Adjuvant Radiotherapy Versus Observation Alone, After Radical Prostatectomy in High Risk Prostate Cancer

Revista da Associacao Medica Brasileira
Medicine
2015English

Population-Based Referrals for Adjuvant Radiotherapy After Radical Prostatectomy in Men With Prostate Cancer: Impact of Randomized Trials

Clinical Genitourinary Cancer
OncologyUrology
2014English

Radical Radiotherapy for High-Risk Prostate Cancer in Older Men

Oncologist
Cancer ResearchMedicineOncology
2012English

Evaluation of the Effectiveness of Adding Androgen Deprivation to Modern Dose-Escalated Radiotherapy for Men With Favorable Intermediate-Risk Prostate Cancer

Cancer
Cancer ResearchOncology
2016English

Adjuvant Versus Early Salvage Radiotherapy: Outcome of Patients With Prostate Cancer Treated With Postoperative Radiotherapy After Radical Prostatectomy

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer

JAMA - Journal of the American Medical Association
Medicine
2006English

Outcomes of Extremely Low Risk Prostate Cancer Following Radical Prostatectomy

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy